Is surgery abroad safe? What the data actually shows

In 2023 the Office for National Statistics counted around 431,000 trips abroad by UK residents for medical treatment; its provisional estimate for 2024 is higher again — well over 400,000 people a year, every year, and rising. Against that denominator, the recorded numerators are strikingly small: 198 complication cases reaching BAAPS surgeons across two years; seven deaths in Turkey known to the FCDO in 2025. Divide naively and you'd conclude serious recorded harm affects a fraction of one percent of medical travellers. That arithmetic is honest about what it shows — and we should be equally honest about what it hides.

It hides undercounting on one side: BAAPS captures only patients who reached its member surgeons, not those treated in A&E, by other specialties, privately, or not at all — and the FCDO only knows about deaths reported to it. It hides over-counting on the other: the ONS figure includes every kind of treatment, dentistry above all, so the denominator for surgery specifically is much smaller than 431,000. The truthful statement is this: nobody — not the NHS, not the regulators, not the clinics, and not this site — publishes a real complication rate for surgery abroad. Any page quoting you a precise percentage, reassuring or terrifying, made it up.

What we can do is compare orders of magnitude with surgery at home — because home is not zero-risk either. In 2024/25 the UK Health Security Agency's surveillance of NHS hospitals found surgical-site infection rates ranging from 0.4% for the cleanest procedures to over 10% for large-bowel surgery. National Joint Registry data shows around 4% of hip and knee replacements are revised within ten years. Those are different measures than the tourism studies — recorded per-operation, not per-traveller — and can't be directly compared. The point of setting them side by side is narrower: every operating theatre in the world carries risk. The question is never 'abroad or safe?' — it's whether a specific provider manages that risk as well as a good one at home would.

If you're on an NHS waiting list for a hip, a knee, a cataract or a hernia, the headlines above are mostly about a different market than the one you'd be entering. The recorded harm concentrates in high-volume budget cosmetic and bariatric packages: procedures marketed on price and holiday framing, sold with deposit pressure, performed on patients accepted after a WhatsApp questionnaire, with recovery compressed to fit a package week. A BBC investigation of weight-loss surgery abroad found budget clinics willing to accept patients below the UK's clinical eligibility thresholds — screening laxity a responsible UK bariatric team would refuse. That is a business-model problem, not a geography problem.

Elective NHS-waitlist procedures abroad tend to happen in a different setting: established orthopaedic and ophthalmic hospitals, often ones that also treat EU state-funded patients under schemes like the S2 route — which requires treatment within a country's public system — and that hold international accreditations you can verify yourself in the Joint Commission International's public directory. None of that makes any individual clinic safe. It means the risk profile of 'a hip replacement at an accredited Lithuanian orthopaedic hospital' and 'a discount tummy tuck package' are not the same thing, however often they share a headline.

Honesty requires the reverse caveat too: there is far less published outcome data for waitlist procedures done abroad than for the cosmetic sector — no UK registry follows your hip to Kaunas or your cataract to Istanbul. You are trading a system with published outcomes for one where you must do the verifying yourself. That is the real safety difference, and it's why the checks in the next section do more work than any national statistic.

The evidence points to a short list of variables that separate good outcomes from bad, and country of treatment is not at the top of it. First: patient selection. A clinic that takes your full history, asks hard questions, and is willing to refuse you is displaying the single strongest safety signal there is; the recorded disasters cluster in clinics that accept almost anyone. Second: who operates. A named surgeon, verifiable on the destination country's medical register, doing your procedure at volume — not 'our surgical team'. Third: the setting. A hospital with intensive-care capability behind it is a different proposition from a standalone clinic when something goes wrong on the table.

Fourth: what happens after. Complications of surgery mostly declare themselves in the first weeks — after a medical traveller has flown home. NHS advice is not to fly for five to seven days after breast surgery or liposuction and seven to ten after abdominal or facial procedures, because of clot risk; a package that compresses that window has priced your deep-vein thrombosis into its hotel bill. The safe pattern is a written aftercare plan, a named UK follow-up route arranged before you travel, and specialist insurance that covers complications of planned treatment — ordinary travel insurance almost never does. Every one of those is checkable before you pay a deposit.

That's the honest conclusion the data supports: safety abroad is mostly decided before the flight, by verification you can do from your sofa. It is also exactly what this site exists for — checking the claims clinics make, procedure by procedure, so the pattern above is easier to apply than to describe. Whether any surgery abroad is right for your case remains a clinical question for your GP and specialist. What the data removes is the two lazy answers: 'it's all a horror show' and 'it's all fine'. Neither survives contact with the numbers.